Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06605872 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

DigiDiab Pilot: Impact Study Hospital

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Final enrollment: 731 participants (planned 500) · Primary completion date changed from estimate of Sep 15, 2025 to Jan 15, 2026 · Study completion date changed from estimate of Oct 31, 2025 to Jan 31, 2026 · 2 more Show 5 more changesShow less
    • Final enrollment: 731 participants (planned 500)
    • Primary completion date changed from estimate of Sep 15, 2025 to Jan 15, 2026
    • Study completion date changed from estimate of Oct 31, 2025 to Jan 31, 2026
    • Eligibility criteria expanded, about 15 words
    • Site details revised
  2. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Nov 1, 2024 to Apr 1, 2025 · Primary endpoint revised · Study sites: 0 to 1 · 1 morev2 Show 4 more changesShow less
    • Start date changed from estimate of Nov 1, 2024 to Apr 1, 2025
    • Primary endpoint revised
    • Study sites: 0 to 1
    • Secondary endpoints revised (3)

    See this version in full on ClinicalTrials.gov ↗

  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
GlucoTab is an innovative workflow and decision support tool for standardised diabetes management by healthcare professionals which provides automated and personalised dosage recommendations for different insulin therapy regimens.
Trial Details
NCT Number NCT06605872
Lead Sponsor Medical University of Graz
Conditions Type 2 Diabetes
Enrollment 731 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov